![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Medtronic Receives CE Mark for Thoracic Stent Graft
Medtronic Receives CE Mark for Thoracic Stent Graft
November 14, 2018
Medtronic received a CE Mark for its Valiant Navion thoracic stent graft, used to repair lesions in the descending aorta.
The stent graft is intended for use in minimally invasive therapies to treat a variety of aortic conditions, including thoracic aortic aneurysms, blunt traumatic aortic injuries, intramural hematomas and type B aortic dissections.
The device is a low-profile version of the company’s Captivia thoracic stent system and allows patients with small iliac arteries to undergo thoracic endovascular aneurysm repairs.
Upcoming Events
-
21Oct